Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platform-Based Mild Cognitive Impairment (MCI) Trial to Address Maladaptive Behaviors

NCT03987464 is registered in ClinicalTrials.gov with Allison Gibson as lead sponsor.

NCT NCT03987464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03987464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platform-Based Mild Cognitive Impairment (MCI) Trial to Address Maladaptive Behaviors
Lead sponsor
Allison Gibson
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2019
Completion date
December 14, 2021
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment